|
The Indian pharmaceutical industry has shown tremendous progress in terms of infrastructure development, technology base creation and a wide range of production. Even while undergoing restructuring, it has established its presence and determination to flourish in the changing environment. The industry now produces bulk drugs belonging to all major therapeutic groups. environment. The industry now produces bulk drugs belonging to all major therapeutic groups. Strong scientific and technical manpower and pioneering work done in process development have contributed to this. Total production of bulk drugs and formulations during 1997-98 is estimated at Rs. 26280 million and Rs. 120680 million respectively. The growth rate has been around 15% for bulk drugs and 20% for formulations during ninetees. The performance on the export front is also noteworthy, clocking a growth rate of more than 20% in 1997-98. Nevertheless, the scope to increase the volume of exports is tremendous. The following form the basis of the technological strengths of the Indian pharmaceutical industry:-
a) Self-reliance displayed by the production of 70% of bulk drugs and almost the entire requirement of formulations within the country.
b) Low cost of production.
c) Low R&D costs.
d) Innovative Scientific manpower.
e) Strength of National Laboratories.
f) Increasing balance of trade in pharma sector.
|
